BRCA1 and polycystic ovary syndrome: These findings suggest that BRCA1 mitigates PCOS phenotypes primarily by suppressing ERS and downstream inflammatory/oxidative and apoptotic pathways, thereby highlighting BRCA1 as a potential molecular target for PCOS therapy.